Inhaled Antibiotics for Mycobacterial Lung Disease

Mycobacterial lung diseases are an increasing global health concern. Tuberculosis and nontuberculous mycobacteria differ in disease severity, epidemiology, and treatment strategies, but there are also a number of similarities. Pathophysiology and disease progression appear to be relatively similar b...

Descripción completa

Detalles Bibliográficos
Autores principales: Banaschewski, Brandon, Hofmann, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680843/
https://www.ncbi.nlm.nih.gov/pubmed/31331119
http://dx.doi.org/10.3390/pharmaceutics11070352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680843/
https://www.ncbi.nlm.nih.gov/pubmed/31331119
http://dx.doi.org/10.3390/pharmaceutics11070352

Ejemplares similares